Overview
- 86 inspections across 84 sites are on record.
- 138 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2022-01-07.
At a glance
Inspections
86
Sites
84
Observations
138
Career since
Jan 2016
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Elaine E. Tseng, M.D. | 7 Jan 2022 | Medical Devices & Rad Health | View 483 → |
| Elaine E. Tseng, M.D. | 7 Jan 2022 | Medical Devices & Rad Health | View 483 → |
| MYOVANT SCIENCES, INC | 17 Dec 2021 | Human Drugs | |
| Leila Chaychi, M.D. | 22 Oct 2021 | Human Drugs | View 483 → |
| Charles River Laboratories, Inc. | 30 Jul 2021 | Biologics |
Sites inspected
Elaine E. Tseng, M.D.San Francisco, United States2 insp.
MYOVANT SCIENCES, INCBrisbane, United States1 insp.
Leila Chaychi, M.D.San Carlos, United States1 insp.
Charles River Laboratories, Inc.Reno, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Linh Tu3 shared
Humberto Z Gomez3 shared
Jeanne J Thai3 shared
Stuart W Russell3 shared
Steven M Galvez3 shared
Marlo-Ian M Alintanahin2 shared
Juanita Banuelos2 shared
Dustin R Abaonza2 shared
Zhou Chen2 shared
Joseph Tibay2 shared
Full investigator report
Get the verbatim findings behind Dustin P Tran's 138 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site